Immunologic properties of Epstein-Barr virus-seronegative adults

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1248-1251

  Jabs, W J ^a   Wagner, H J ^b   Neustock, P ^b   Kluter H ^b   Kirchner, H ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOKINE; MONOKINE;

ADULT; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN EXPERIMENT; INFECTION RESISTANCE; INTERFERON PRODUCTION; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NEWCASTLE DISEASE PARAMYXOVIRUS; NORMAL HUMAN; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; VIRUS IMMUNITY; VIRUS INFECTION;

EID: 0029953755     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1248     Document Type: Article

References (15)

1. Miller G. Epstein-Barr virus: physiology, pathogenesis, and medical aspects. In: Fields BN, ed. Virology. New York: Raven Press, 1990:1921-58.
2. Yao QY, Rickinson AB, Epstein MA. A reexamination of Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 1985;35:35-42.
3. Schuster V, Kreth HW. Epstein-Barr virus infection and associated diseases in children. Eur J Pediatr 1992;151:718-25.
4. Foss HD, Herbst H, Hummel M, et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994;83:707-12.
5. Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH. Release of lymphokines after Epstein-Barr virus infection in vitro. I. Sources and kinetics of production of interferons and interleukins in normal humans. J Immunol 1986;136:3636-42.
6. de-Thé G, Day NE, Geser A, et al. Seroepidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. In: de-Thé G, Epstein MA, zur Hausen H, eds. Oncogenesis and herpesviruses II. Lyon, France: IARC Scientific Publication, 1975;11:3-18.
7. Kirchner H, Kleinicke C, Digel W. A whole blood technique for testing production of human interferon by leukocytes. J Immunol Methods 1982;48:213-9.
8. Gervais F, Willis A, Leyritz M, Lebrun A, Joncas JH. Relative lack of Epstein-Barr virus (EBV) receptors on B cells from persistently EBV seronegative adults. J Immunol 1981;126:897-900.
9. O'Garra A, de-Waal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
10. Katschinski DM, Neustock P, Klüter H, Kirchner H. Influence of various factors on interferon-α production in cultures of human lymphocytes. 1. J Interferon Res 1994;14:105-10.
11. Kirchner H. The interferon system as an integral part of the defense system against infections. Antiviral Res 1986;6:1-17.
12. Thorley-Lawson DA. The transformation of adult but not newborn human lymphocytes by Epstein-Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein-Barr virus infection is mediated by interferon. J Immunol 1981;126:829-33.
13. Delcayre AX, Lotz M, Lernhardt W. Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-α): immediate antiviral activity of IFN-α during the early phase of infection. J Virol 1993;67:2918-21.
14. Kure S, Tada K, Wada J, Yoshie O. Inhibition of Epstein-Barr virus infection in vitro by recombinant human interferon alpha and gamma. Virus Res 1986;5:377-88.
15. Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W. Epstein-Barr virus/complement C3d receptor is an interferon α receptor. EMBO J 1991;10:919-26.